SCHEMBL7659676

SCHEMBL7659676

CN(CC(O)C(O)CO)C(=O)c1cccc(C(=O)N(C)CC(O)C(O)CO)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.37
TDP1 Q9NUW8 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
ACMSD Q8TDX5 1/20 0.36
L3MBTL1 Q9Y468 3/20 0.35
NPC1 O15118 2/20 0.35
MCL1 Q07820 2/20 0.35
RAB9A P51151 2/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
MAPK1 P28482 1/20 0.35
RECQL P46063 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
CNR1 P21554 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7651990 0.86 ROCK2 (0.39) CYP1A2TDP1KDM4EALOX15TSHR
SCHEMBL7104690 0.84 CNR1 (0.30) CNR1
SCHEMBL7655284 0.84 CYP1A2 (0.39) CYP1A2TDP1KDM4EALOX15TSHR
SCHEMBL7107240 0.81 MEN1 (0.35) MEN1KMT2ACNR1
SCHEMBL7663905 0.78 CYP1A2 (0.37) CYP1A2TDP1KDM4EALOX15TSHR
SCHEMBL7658827 0.77 P4HTM (0.36) KDM4EL3MBTL1MAPK1KMT2A
SCHEMBL7661222 0.73 TDP1 (0.41) CYP1A2TDP1KDM4EALOX15TSHR
SCHEMBL28628270 0.72 KDM4E (0.59) CYP1A2TDP1KDM4EALOX15TSHR
SCHEMBL7656251 0.72 KDM4E (0.39) CYP1A2TDP1KDM4EALOX15TSHR
SCHEMBL7662443 0.72 KMT2A (0.36) KDM4ETSHRL3MBTL1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 US claimed
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 US disclosed